Edwards Lifesciences Corp (EW)
86.79
-1.22
(-1.39%)
USD |
NYSE |
Apr 26, 11:41
Edwards Lifesciences Cash from Financing (TTM): -711.00M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -711.00M |
| September 30, 2023 | -1.136B |
| June 30, 2023 | -1.063B |
| March 31, 2023 | -1.423B |
| December 31, 2022 | -1.584B |
| September 30, 2022 | -808.10M |
| June 30, 2022 | -699.20M |
| March 31, 2022 | -450.10M |
| December 31, 2021 | -356.30M |
| September 30, 2021 | -252.90M |
| June 30, 2021 | -257.90M |
| March 31, 2021 | -174.80M |
| December 31, 2020 | -486.90M |
| September 30, 2020 | -491.30M |
| June 30, 2020 | -490.90M |
| March 31, 2020 | -746.40M |
| December 31, 2019 | -115.60M |
| September 30, 2019 | -997.30M |
| June 30, 2019 | -1.088B |
| March 31, 2019 | -1.098B |
| December 31, 2018 | -1.101B |
| September 30, 2018 | -485.50M |
| June 30, 2018 | -408.50M |
| March 31, 2018 | -41.00M |
| December 31, 2017 | -473.20M |
| Date | Value |
|---|---|
| September 30, 2017 | -239.10M |
| June 30, 2017 | -195.60M |
| March 31, 2017 | -290.70M |
| December 31, 2016 | -268.50M |
| September 30, 2016 | -333.30M |
| June 30, 2016 | -373.50M |
| March 31, 2016 | -455.80M |
| December 31, 2015 | -158.60M |
| September 30, 2015 | -53.00M |
| June 30, 2015 | -27.90M |
| March 31, 2015 | -81.10M |
| December 31, 2014 | -153.00M |
| September 30, 2014 | -118.40M |
| June 30, 2014 | -98.50M |
| March 31, 2014 | -84.00M |
| December 31, 2013 | 34.90M |
| September 30, 2013 | -192.50M |
| June 30, 2013 | -261.60M |
| March 31, 2013 | -177.40M |
| December 31, 2012 | -155.60M |
| September 30, 2012 | -62.30M |
| June 30, 2012 | -159.00M |
| March 31, 2012 | -197.80M |
| December 31, 2011 | -135.20M |
| September 30, 2011 | -108.20M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-1.584B
Minimum
Dec 2022
-115.60M
Maximum
Dec 2019
-701.77M
Average
-699.20M
Median
Jun 2022
Cash from Financing (TTM) Benchmarks
| Stryker Corp | -1.594B |
| Boston Scientific Corp | 5.00M |
| Align Technology Inc | -598.34M |
| Abbott Laboratories | -7.091B |
| Steris PLC | -133.36M |